Trials / Completed
CompletedNCT03807661
Percutaneous Deep Vein Arterialization Post-Market Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- LimFlow SA · Industry
- Sex
- All
- Age
- 21 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this post-market study is to evaluate the safety and effectiveness of the LimFlow System in creating a below-the-knee arterio-venous fistula for venous arterialization in subjects with critical limb ischemia.
Detailed description
This study will investigate the safety and effectiveness of the LimFlow System for creating an arterio-venous fistula in the below-the-knee vascular system using an endovascular, minimally invasive approach for the treatment of critical limb ischemia in subjects ineligible for conventional endovascular or surgical limb salvage procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous deep vein arterialization | Creation of an arterio-venous fistula in the below-the-knee vasculature using the LimFlow System endovascular, minimally invasive approach |
| DEVICE | LimFlow System | Creation of an arterio-venous fistula in the below-the-knee vasculature using the LimFlow System endovascular, minimally invasive approach |
Timeline
- Start date
- 2019-12-11
- Primary completion
- 2023-10-09
- Completion
- 2024-10-28
- First posted
- 2019-01-17
- Last updated
- 2026-01-16
- Results posted
- 2025-11-28
Locations
6 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03807661. Inclusion in this directory is not an endorsement.